SRK-373

N/A

Report date: 2025/05/15 11:45:58

Base Information

Drug NameSRK-373
Drug Alias NameSRK-373
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Transforming growth factor beta 1
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScholar Rock Inc
China Registration ClassN/A

Develop Information

Active CompaniesScholar Rock Inc
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A